JulieRGralowMD

PubMed

• 43 citations
  Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine Study.
  Costanza Paoletti, Jieling Miao, Emily M. Dolce, Elizabeth P. Darga, Madeline Repollet
  Clinical Cancer Research. 2019-10-15
• 774 citations
  Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, pla...
  Paul M. Ridker, Jean G. MacFadyen, Tom Thuren, Brendan M. Everett, Peter Libby
  Lancet. 2017-10-21
• 2 citations
  Reduced Cancer-Related Fatigue after Tablet-Based Exercise Education for Patients.
  Diana J Wilkie, Anna L Schwartz, Wen-Chun Liao, Dottington Fullwood, Yu Wu
  Cancer Control. 2022-04-13

Journal Articles

• Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230  
  Carol J Fabian, Julie R Gralow, Journal of the National Cancer Institute
• Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer  
  Aminah Jatoi, Antonio C Wolff, Harvey Jay Cohen, Rachel A Freedman, Gustav Magrinat, Julie Gralow, Gretchen Kimmick, Heidi D Klepin, Harold Burstein, Hyman Muss, Jeann..., Journal of the American Geriatrics Society
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemothe...  
  Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL, Davidson NE, Sledge GW, Winer EP, Hudis C, Ingle JN, Perez EA, Pr..., Lancet Oncol
• Intensive dose-dense compared with high-dose adjuvant chemotherapy for high risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.  
  Moore H, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow WE, Hudis C, Wolff AC, Ingle JN, Chew HK, Elias AD, Livingston RB, Martino S, J Clin Oncol
• Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.  
  Sparano JA, Pisano ED, White JR, Hunt KK, Mamounas EP, Perez EA, Hortobagyi GN, Gralow JR, Comis RL, Breast Cancer Res Treat
• Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic ...  
  Sparano JA, Hortobagyi GN, Gralow JR, Perez EA, Comis RL, Breast Cancer Res Treat
• Early detection of breast cancer: new biomarker tests on the horizon?  
  Jotwani AC, Gralow JR, Mol Diagn Ther
• Effects of Denosumab in Patients with Bone Metastases, with and without Previous Bisphosphonate Exposure.  
  Body JJ, Lipton A, Gralow J, Steger GG, Gao G, Yeh H, Fizazi K, J Bone Miner Res
• Adjuvant chemotherapy in older women with early-stage breast cancer.  
  Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC,..., N Engl J Med
• Breast Cancer Advocacy: Changing Perceptions.  
  Koon K, Soldak T, Gralow J, PMID
• Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology.  
  Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz P, Kramer B, Kris M, Markman M, Mayer R, Pfister D, Raghavan D, Ramsey S, Reaman G, Sandler..., J Clin Oncol
• A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.  
  Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R, Clin Breast Cancer
• Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compare...  
  Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, M..., J Clin Oncol
• Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer.  
  Bunnell C, Vahdat L, Schwartzberg L, Gralow J, Klimovsky J, Poulart V, Peck R, Thomas E, Clin Breast Cancer
• Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies.  
  Coleman RE, Body JJ, Gralow JR, Lipton A, Cancer Treat Rev
• Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.  
  Gralow J, Rugo H, Gradishar W, O'Shaughnessy JA, Jahanzeb M, Perez E, Tripathy D, Clin Breast Cancer
• Major depression after breast cancer: a review of epidemiology and treatment.  
  Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow J, Gen Hosp Psychiatry
• Major Research Advances in Cancer Treatment, Prevention, and Screening: A Report from the American Society of Clinical Oncology.  
  Grralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W Jr, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Rams..., J Clin Oncol
• Patient training in cancer pain management using integrated print and video materials: A multisite randomized controlled trial.  
  Syrjala KL, Abrams JR, Polissar NL, Hansberry J, Robison J, Dupen S, Stillman M, Fredrickson M, Rivkin S, Feldman E, Gralow J, Rieke JW, Raish RJ, Lee DJ, Cleeland CS,..., Pain
• Helping her heal: A pilot study of an educational counseling intervention for spouses of women with breast cancer.  
  Lewis FM, Cochrane BB, Fletcher KA, Zahlis EH, Shands ME, Gralow JR, Wu SM, Schmitz K, Psychooncology
• Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.  
  Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, Davidson NE, N Engl J Med
• Guidance on the use of bisphosphonates in solid tumors: recommendations of an international expert panel.  
  Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, Crinò L, Dirix L, Gnant M, Gralow J, Hadji P, Hortobagyi GN, Jonat W, Lipton A, Monnier A, Paterson A..., Ann Oncol
• Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening - A report from the American Society of Clinical Oncology.  
  Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ Jr, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schi..., J Clin Oncol
• Serial 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progre...  
  Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunnwald LK, Mankoff DA, Breast Cancer Res Treat
• Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.  
  Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, ..., Breast
• Join now to see all

Books/Book Chapters

• Medical Therapeutics. 
  Chapter: Oncologic Therapeutics 
  Gralow JR, Livingston RL, Hunt K, Petersdorf SEditors: Ramsey P and Larson EB.W.B. Saunders Co
• Cancer Patient Follow-Up. 
  Chapter: Breast Cancer Patient Follow-Up 
  Gralow JR, Anderson BOEditors: Johnson, F. and Virgo, K.S.Moseby-Year Book, Inc
• Vaccines Against Virally Induced Cancers. 
  Chapter: Immunity to the HER-2/neu Oncogenic Protein 
  Page 198 - 211Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MAJohn Wiley & Sons, Inc
• Proceedings of the Second International Conference on Malignant Lymphoma. 
  Chapter: The Immunology of B-Cell Lymphoma. Studies with Anti-Idiotype Antibodies 
  Levy R, Meeker TC, Lowder JN, Maloney D, Thielmans K, Gralow J, Warnke R, Cleary ML, Sklar JMartinus Nishoff Publishing, Boston, MA
• Finding Your Way to Wellness: A Puget Sound Breast Cancer Information and Resource guide. 
  Gralow JRPeanut Butter Publishing
• Finding Your Way to Wellness: A Puget Sound Breast Cancer Information and Resource guide. 
  Gralow JREditors: Susan G.Komen Breast Cancer FoundationEdition 3rd,
• Diseases of the Breast. 
  Chapter: Adjuvant Systemic Therapy: Bisphosphonates 
  Gralow JREditors: Harris JR, Lippman ME, Morrow M, Osborne CK.Lippincott, Williams & WilkinsEdition 4th,
• Principles and Practice of Fertility Preservation. 
  Chapter: Breast cancer therapy and reproduction 
  Page 62 - 72Korde L, Gralow JREditors: Donnez J and Kim SS.Cambridge University Press
• Cancer rehabilitation and survivorship: Transdisciplinary approaches to personalized care. 
  Chapter: Recurrence and second primary cancers 
  Koon KP, Gralow JREditors: J.L. Lester & P. Schmitt.Oncology Nursing Society, Pittsburgh, PA
• Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. 
  Chapter: Core elements for provision of cancer care and control in low and middle income countries 
  Shulman L, Gralow J, Krakauer E, Anderson BO, Porter P, Gospodarowicz M, Feldman S, Rodriguez-Galindo C, Frazier L, Lehmann LEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
• Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. 
  Chapter: Innovative delivery of cancer care and control in low-resource scenarios 
  Knaul FM, Bhadelia A, Gralow J, Langer AEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
• Closing the Cancer Divide: A Blueprint to Expand Access in Low and Middle Income Countries. 
  Chapter: Access to affordable medicines, vaccines, and health technologies for cancer: overcoming price and non-price barriers to access 
  Quick J, Konduri N, Gralow JEditors: Knaul FM, Frenk, J, Shulman L.Harvard Global Equity Initiative, Boston, MA
• Closing the Cancer Divide: An Equity Imperative. 
  Knaul FM, Gralow JR, Atun R, Bhadelia AHarvard University Press, Boston, MA
• Join now to see all

Abstracts/Posters

• Spontaneous and Induced Immunoglobulin Secretion and Differentiation in Human B-Cell Lymphomas and Leukemias.
  Gralow J, Levy R, Miller RA, Federation Proceedings, Federation of American Societies for Experimental Biology
• Southern Blotting of DNA from Formalin-Fixed, Paraffin Embedded Tissue.
  Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, International Academy of Pathology
• Recovery of Intact, High Molecular Weight DNA from Formalin-Fixed, Paraffin Embedded Pathology Specimens.
  Dubeau L, Chandler L, Gralow J, Nichols PW, Jones PA, American Urological Association
• Methylation Patterns of the Alpha-Lactalbumin Gene in Human Mammary Carcinoma: A Model for Identification of the Origin of Metastatic Tumors.
  Gralow JR, Dubeau L, Jones PA, Clinical Research
• Existent T cell and Antibody Immunity to HER-2/neu Protein in Breast Cancer Patients.
  Disis ML, Bernhard H, Gralow JR, Cheever MA, The American Association for Cancer Research
• Immunization to oncogenic HER-2/neu protein with peptide based vaccines.
  Disis ML, Gralow JR, Bernhard H, Hand S, and Cheever MA, The American Association for Cancer Research
• Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.
  Bernhard H, Disis ML, Huseby E, Hand S, Gralow JR, Risdon G, Heimfeld S, and Cheever MA, Keystone Symposia
• HER-2/neu Specific Immunity Can Be Induced by Therapy with 2B1, a Bispecific Antibody Binding to HER-2/neu and CD16.
  Gralow JR, Weiner LM, Ring D, Clark J, Alpaugh RK, Disis ML, Cheever MA, IVth International Conference on Bispecific Antibodies and Targeted Cellular Toxicity
• GM-CSF: An effective adjuvant for peptide based vaccines.
  Disis ML, Bernhard H, Shiota F, Hand S, Gralow JR, and Cheever MA, The Ninth International Congress of Immunology
• Bispecific Monoclonal Antibody-Promoted Induction of the Idiotype Cascade in a Phase I Clinical Trial.
  Clark JI, Gralow JR, Alpaugh RK, Disis ML, Cheever MA, Ring D, and Weiner LM, The American Association for Cancer Research
• Therapeutic Efficacy of Doxorubicin Immunoconjugates Targeting the HER-2/neu Oncogenic Protein in a Human Breast Cancer Cell Line.
  Specht JS, Sivam GP, Gralow JR, Journal of Investigative Medicine
• [Tc-99M]-Sestamibi Scintimammography to Measure the Breast Cancer Response to Neo-Adjuvant Chemotherapy.
  Mankoff DA, Gralow JR, Dunnwald LK, Drucker MJ, Ellis G, Livingston RB, Journal of Nuclear Medicine
• Monitoring Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients Using [Tc-99m]-Sestamibi Scintimammography.
  Mankoff DA, Gralow JR, Dunnwald LK, Drucker MJ, Ellis G, Livingston RB, The American Society of Clinical Oncology
• Monitoring and Predicting the Response of Breast Cancer to Neo-adjuvant Chemotherapy Using [TC99m]-Setstamibi Scintimammography.
  Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston R, Society of Nuclear Medicine
• Taxol by 96-hour Infusion and Sequential Navelbine with GCSF Support as Salvage Therapy for Breast Cancer. A Phase I-II Study.
  Livingston RB, Gralow JR, Ellis GK, Williams MA, Bristol Myers Squibb Investigator’s Meeting
• The Role of Imaging Modalities in the Diagnosis and Treatment of Breast Cancer.
  Gralow JR, Mankoff DA, Society of Nuclear Medicine, Western Section
• Combined PET and Surface Coil MRI Imaging in the Diagnosis of Recurrent Breast Cancer in the Axilla.
  Mankoff DA, Maravilla K, Austin-Seymour M, Ellis GK, Hayes C, Gralow JR, Cortese AA, Moe R, San Antonio Breast Cancer Symposium
• Therapeutic Efficacy of Doxorubicin Immunoconjugates Targeting the HER-2/neu Oncogenic Protein in Human Breast Cancer.
  Specht JS, Sivam GP, Gralow JR, the American Society of Clinical Oncology
• Cellular Tumor Markers as Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer.
  Zapf ML, Folpe AL, Storer BE, Gown AM, Ellis GK, Livingston RB, Gralow JR, Breast Ca Res and Treat
• Monitoring Locally Advanced Breast Cancer Treatment Response using [Tc-99m]-Sestamibi scintimammography.
  Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston R, Breast Ca Res and Treat
• Continuous Adriamycin and Cyclophosphamide with GCSF Feasible with High Dose Intensity, Low Risk of Hospitalization.
  Ellis GK, Williams M, Gralow J, Long C, Livingston RB, Breast Ca Res and Treat
• Alterations in Breast Cancer Protein Expression Following Neoadjuvant Doxorubicin-based Chemotherapy.
  Gralow JR, Zapf ML, Folpe AL, Ellis GK, Livingston RB, Gown AM, Breast Ca Res and Treat
• IL-12 Induces Cytolytic Activity in Lymphocytes from Breast Cancer Patients after High Dose Therapies.
  Lindgren C, Markowitz D, Gralow J, Keeler T, Bennett S, Golden J, Bensinger W, Holmberg L, Thompson JA, Fefer A, the American Society of Clinical Oncology
• Breast Cancer Tumor Associated Proteins as Predictors of Response to Neoadjuvant Doxorubicin-Based Chemotherapy.
  Zapf ML, Folpe AL, Storer BE, Gown AM, Ellis GK, Livingston RB, Gralow JR, the American Society of Clinical Oncology
• Paclitaxel/Vinorelbine Chemotherapy with Concurrent G-CSF for Metastatic Breast Cancer: Phase I-II Study in Doxorubicin-Treated Patients.
  Ellis GK, Gralow JR, Pierce HI, Williams MA, Livingston RB, the American Society of Clinical Oncology
• Join now to see all

Lectures

• What Is Implementation Science and the Breast Cancer Initiative 2.5 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018